bi-1607
Showing 1 - 1 of 1
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,
Recruiting
- HER2-positive Breast Cancer
- +4 more
- BI-1607
- Trastuzumab
-
Essen, Germany
- +5 more
Nov 15, 2022